Evidence map›Paper›PMID 26396247›Full record

ArticlemBio2015

Virome Analysis of Transfusion Recipients Reveals a Novel Human Virus That Shares Genomic Features with Hepaciviruses and Pegiviruses.

Amit Kapoor, Arvind Kumar, Peter Simmonds, Nishit Bhuva, Lokendra Singh Chauhan, Bohyun Lee, Amadou Alpha Sall, Zhezhen Jin, Stephen S Morse, Beth Shaz and 2 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 101 citations in OpenAlex.

  1. Trial
  2. Article
  3. Oral and plasma microbiome in the context of acute febrile illness.medRxiv : the preprint server for health sciences · 2026
    Article
  4. Characterization of near-complete humanMicrobiology resource announcements · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Blood Virome: A new frontier in biomedical science.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Amit KapoorCenter for Infection and Immunity, Columbia University, New York, New York, USA ak.3117@columbia.edu.
Arvind KumarCenter for Infection and Immunity, Columbia University, New York, New York, USA.
Peter SimmondsRoslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
Nishit BhuvaCenter for Infection and Immunity, Columbia University, New York, New York, USA.
Lokendra Singh ChauhanCenter for Infection and Immunity, Columbia University, New York, New York, USA.
Bohyun LeeCenter for Infection and Immunity, Columbia University, New York, New York, USA.
Amadou Alpha SallInstitut Pasteur de Dakar, Dakar, Senegal.
Zhezhen JinDepartment of Biostatistics, MSPH, Columbia University, New York, New York, USA.
Stephen S MorseDepartment of Epidemiology, MSPH, Columbia University, New York, New York, USA.
Beth ShazNew York Blood Centers, New York, New York, USA.
Peter D BurbeloDental Clinical Research Core, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
W Ian LipkinCenter for Infection and Immunity, Columbia University, New York, New York, USA.
Columbia University · USInstitut Pasteur · FRNational Institutes of Health · USNew York Blood Center · USUniversity of Edinburgh · GB

Funding

Translational CoreU19AI109761 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LIPKIN, W. IAN · 2014 to 2018
$32.6M
Novel viruses and viral dynamics in multiple transfusion recipientsR01HL119485 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI KAPOOR, AMIT · 2014 to 2018
$2.0M
Study of rodent HCV-GBV like virusesR21AI107631 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI KAPOOR, AMIT · 2014 to 2015
$472k
Intramural NIH HHSNHLBI NIH HHS HL119485NHLBI NIH HHS R01 HL119485NIAID NIH HHS AI107631NIAID NIH HHS AI109761NIAID NIH HHS R21 AI107631NIAID NIH HHS U19 AI109761Wellcome Trust 095831
6 · The paper itself

Abstract

unlabelledTo investigate the transmission of novel infectious agents by blood transfusion, we studied changes in the virome composition of blood transfusion recipients pre- and posttransfusion. Using this approach, we detected and genetically characterized a novel human virus, human hepegivirus 1 (HHpgV-1), that shares features with hepatitis C virus (HCV) and human pegivirus (HPgV; formerly called GB virus C or hepatitis G virus). HCV and HPgV belong to the genera Hepacivirus and Pegivirus of the family Flaviviridae. HHpgV-1 was found in serum samples from two blood transfusion recipients and two hemophilia patients who had received plasma-derived clotting factor concentrates. In the former, the virus was detected only in the posttransfusion samples, indicating blood-borne transmission. Both hemophiliacs were persistently viremic over periods of at least 201 and 1,981 days. The 5' untranslated region (UTR) of HHpgV-1 contained a type IV internal ribosome entry site (IRES), structurally similar to although highly divergent in sequence from that of HCV and other hepaciviruses. However, phylogenetic analysis of nonstructural genes (NS3 and NS5B) showed that HHpgV-1 forms a branch within the pegivirus clade distinct from HPgV and homologs infecting other mammalian species. In common with some pegivirus variants infecting rodents and bats, the HHpgV-1 genome encodes a short, highly basic protein upstream of E1, potentially possessing a core-like function in packaging RNA during assembly. Identification of this new human virus, HHpgV-1, expands our knowledge of the range of genome configurations of these viruses and may lead to a reevaluation of the original criteria by which the genera Hepacivirus and Pegivirus are defined. IMPORTANCE: More than 30 million blood components are transfused annually in the United States alone. Surveillance for infectious agents in the blood supply is key to ensuring the safety of this critical resource for medicine and public health. Here, we report the identification of a new and highly diverse HCV/GB virus (GBV)-like virus from human serum samples. This new virus, human hepegivirus 1 (HHpgV-1), was found in serum samples from blood transfusion recipients, indicating its potential for transmission via transfusion products. We also found persistent long-term HHpgV-1 viremia in two hemophilia patients. HHpgV-1 is unique because it shares genetic similarity with both highly pathogenic HCV and the apparently nonpathogenic HPgV (GBV-C). Our results add to the list of human viruses and provide data to develop reagents to study virus transmission and disease association and for interrupting virus transmission and new human infections.

Indexed as

Genome, ViralMicrobiotaCluster AnalysisFlaviviridaeHumansInternal Ribosome Entry SitesMolecular Sequence DataPhylogenyRNA, ViralSequence Analysis, DNASequence HomologySerumViral Nonstructural ProteinsInternal Ribosome Entry SitesRNA, ViralViral Nonstructural Proteins

Identifiers

PMID26396247
PMCPMC4600124
OpenAlexW1943125084

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.